MICROBIX BIOSYSTEMS MBXBF overview

MISSISSAUGA, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a proudly Ontario Made life sciences innovator, manufacturer, and exporter, was pleased to host Government of Ontario candidates Premier Doug Ford (Etobicoke North riding) and local MPP Deepak Anand (Mississauga-Malton riding). During their site visit on the morning of February 27 — Ontario’s Provincial Election Day — our team had great conversations about how...

MISSISSAUGA, Ontario, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces the issuance of stock options under its shareholder-approved stock option plan (the “Stock Option Plan”), as part of its compensation programs to incentivize and retain its board of directors, executives, and managers. Details of the Option Issuance In consultation with management, Microbix’s Board of...

MISSISSAUGA, Ontario, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to equity investors at the Whistler Capital Event conference, organized by Capital Event Management Ltd. and being hosted at the Fairmont Chateau Whistler, in Whistler, British Columbia, February 21 to 23, 2025. Microbix’s CEO, Cameron Groome, will undertake a series of 18 one-on-one...

MISSISSAUGA, Ontario, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter of fiscal 2025 ended December 31, 2024 (“ Q1 ”). Results for Q1 demonstrated the results of ongoing efforts to increase recurring sales of Microbix’s diagnostic-test related ingredients and devices businesses, work that resulted in a 40% year-over-year increase in such revenues...

MISSISSAUGA, Ontario, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its first quarter of fiscal 2025 ended December 31, 2024 (“ Q1 2025 ”) prior to the start of trading on February 13, 2025. At 11:00 AM ET on that day, Microbix intends to hold a webinar discussion of Q1 2025 results...

MISSISSAUGA, Ontario, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it has received C$ 2.4 million in new equity capital from the partial exercise of expiring share purchase warrants. The warrants were issued in connection with a private placement undertaken in January, 2020, and had an exercise price of C$ 0.36 and a five-year term (the “ 2020 Warrants ”). Originally,...

MISSISSAUGA, Ontario and TRAVERSE CITY, Mich., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, and American Proficiency Institute ( API ), a groundbreaking supplier of proficiency testing (“ PT ”) to over 20,000 clinical laboratories, announce the start of a pilot PT program to ensure that molecular diagnostic (“ MDx ”) assays can detect the emerging H5N1 strain of the Influenza A...

MISSISSAUGA, Ontario, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces its intentions to broaden its platform capabilities to enable production of a wider range of test ingredients (“ Antigens ”) by using recombinant production technologies. Directing existing in-house synthetic biology capabilities to this project will create large-scale recombinant Antigens production to...